Common use of Restrictions on License Clause in Contracts

Restrictions on License. The grant in Section 2.1 shall be further subject to, restricted by and non-exclusive with respect to: (i) the making or use of the Subject Technology and Patent Rights by BCM for non-commercial research, patient care, teaching and other educationally related purposes; (ii) the making or use of the Subject Technology and Patent Rights by the Developers for non-commercial research purposes at academic or research institutions; (iii) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to other academic or research institutions for non-commercial research purposes; (iv) the making or use of the Subject Technology and Patent Rights by academic and research institutions for non-commercial research purposes; and (v) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM is required by law or regulation to grant to the United States of America or to a foreign state pursuant to an existing or future treaty with the United States of America. (vi) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to [*…***…] under […***…] existing material transfer agreements with BCM.

Appears in 2 contracts

Sources: Exclusive License Agreement (Bellicum Pharmaceuticals, Inc), Exclusive License Agreement (Bellicum Pharmaceuticals, Inc)

Restrictions on License. The grant in Section 2.1 shall be further subject to, restricted by and be non-exclusive with respect to: (i) the making or use of the Subject Technology and Patent Rights by BCM for non-commercial research, patient care, teaching and other educationally related purposes; (ii) the making or use of the Subject Technology and Patent Rights by the Developers for non-commercial research purposes at academic or research institutions; (iii) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to other academic or research institutions for non-commercial research purposes; (iv) the making or use of the Subject Technology and Patent Rights by academic and research institutions for non-commercial research purposes; and (v) any non-exclusive nonexclusive license of the Subject Technology and/or Patent Rights that BCM is required by law or regulation to grant to the United States of America or to a foreign state pursuant to an existing or future treaty with the United States of America. (vi) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to [*…***…] under […***…] existing material transfer agreements with BCM.

Appears in 2 contracts

Sources: Exclusive License Agreement (Allovir, Inc.), Exclusive License Agreement (Allovir, Inc.)

Restrictions on License. The grant in Section 2.1 shall be further subject to, restricted by and non-exclusive with respect to: (i) the making or use of the Subject Technology and Patent Rights by BCM for non-commercial research, patient care, teaching and other educationally related purposes; (ii) the making or use of the Subject Technology and Patent Rights by the Developers for non-commercial research purposes at academic or research institutions; (iii) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to other academic or research institutions for non-commercial research purposes; (iv) the making or use of the Subject Technology and Patent Rights by academic and research institutions for non-commercial research purposes; and (v) any non-non exclusive license of the Subject Technology and/or Patent Rights that BCM is required by law or regulation to grant to the United States of America or to a foreign state pursuant to an existing or future treaty with the United States of America. (vi) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to [*…***…] under […***…] existing material transfer agreements with BCM.

Appears in 1 contract

Sources: Exclusive License Agreement (Cara Therapeutics, Inc.)

Restrictions on License. The grant in Section 2.1 shall be further subject to, restricted by and non-exclusive with respect to: (i) the making or use of the Subject Technology and Patent Rights by BCM for non-commercial research, patient care, teaching and other educationally related purposes; (ii) the making or use of the Subject Technology and Patent Rights by the Developers for non-commercial research purposes at academic or research institutions; (iii) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to other academic or research institutions for non-commercial research purposes; (iv) the making or use of the Subject Technology and Patent Rights by academic and research institutions for non-commercial research purposes; and (v) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM is required by law or regulation to grant to the United States of America or to a foreign state pursuant to an existing or future treaty with the United States of America. (vi) any non-exclusive license of the Subject Technology and/or Patent Rights that BCM grants to [*…***…] under […***…] existing material transfer agreements with BCM.

Appears in 1 contract

Sources: Exclusive License Agreement (Fate Therapeutics Inc)